Phone app may ease anxiety in teens and young adults after cancer
NCT ID NCT06682039
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tested a smartphone app designed to help young cancer survivors (ages 15-29) manage anxiety. The app uses attention bias modification (ABM) to retrain how the brain reacts to stressful triggers, along with gratitude exercises. The goal was to see if survivors would use the app and find it helpful. The study enrolled 70 participants and measured how many signed up, completed the program, and reported satisfaction.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- Attention Bias Modification (ABM) smartphone app plus gratitude and savoring activities
- What this could lead to
- If this approach works, it could offer a simple, self-guided way to ease anxiety in young cancer survivors, improving their quality of life.
- What could go wrong
- This was a small, early feasibility study (70 participants) with no control group for effectiveness. It only measured whether people would use the app, not whether it actually reduces anxiety.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
70 people
The number who actually took part.
- Started
-
Nov 2024
- Finished
-
Jan 2026
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
15 to 29 years
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Age 15-29 years * Diagnosis of cancer malignancy * Received active/curative cancer treatment OR received/actively receiving cancer survivorship care at Seattle Children's Hospital (SCH) or other study referring site (e.g. St. Jude) * Currently off active/curative cancer treatment * Patient able to understand/read/write English language * Cognitively able to participate in ABM intervention and complete surveys * Patient has access to smartphone able to send and receive text messages * Patient has access to computer or smartphone for Inquisit program Exclusion Criteria: * Patients on active/curative cancer treatment * Cognitively or physically unable to participate in ABM intervention and surveys * Patients who cannot understand/read/write English will be excluded from the research because the ABM intervention is currently only available in English * Furthermore, patients who do not have access to technology (smartphone/computer) will be excluded from the study as this technology is absolutely required to engage in the study intervention
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Childhood hematopoietic and lymphatic system neoplasm are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Fred Hutch/University of Washington/Seattle Children's Cancer Consortium
Seattle, Washington, 98109, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.